Del Paggio JC - Search Results

1

Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefit.

Grössmann N, Del Paggio JC, Wolf S, Sullivan R, Booth CM, Rosian K, Emprechtinger R, Wild C. Grössmann N, et al. Among authors: del paggio jc. Eur J Cancer. 2017 Sep;82:66-71. doi: 10.1016/j.ejca.2017.05.029. Epub 2017 Jul 10. Eur J Cancer. 2017. PMID: 28648700 Free article.

2

Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?

Del Paggio JC, Azariah B, Sullivan R, Hopman WM, James FV, Roshni S, Tannock IF, Booth CM. Del Paggio JC, et al. Ann Oncol. 2017 Jan 1;28(1):157-162. doi: 10.1093/annonc/mdw538. Ann Oncol. 2017. PMID: 27742650 Free article.

3

Cancer care in South India: perspectives from visiting Canadian oncologists.

Karim S, Del Paggio JC, Berry SR, Booth CM. Karim S, et al. Among authors: del paggio jc. Curr Oncol. 2016 Dec;23(6):e527-e529. doi: 10.3747/co.23.3411. Epub 2016 Dec 21. Curr Oncol. 2016. PMID: 28050140 Free PMC article. No abstract available.

4

Approvals in 2016: questioning the clinical benefit of anticancer therapies.

Booth CM, Del Paggio JC. Booth CM, et al. Among authors: del paggio jc. Nat Rev Clin Oncol. 2017 Feb 20;14(3):135-136. doi: 10.1038/nrclinonc.2017.18. Nat Rev Clin Oncol. 2017. PMID: 28218259 No abstract available.

5

Lymph node evaluation for colon cancer in routine clinical practice: a population-based study.

Del Paggio JC, Nanji S, Wei X, MacDonald PH, Booth CM. Del Paggio JC, et al. Curr Oncol. 2017 Feb;24(1):e35-e43. doi: 10.3747/co.24.3210. Epub 2017 Feb 27. Curr Oncol. 2017. PMID: 28270730 Free PMC article.

6

Population-based study to re-evaluate optimal lymph node yield in colonic cancer.

Del Paggio JC, Peng Y, Wei X, Nanji S, MacDonald PH, Krishnan Nair C, Booth CM. Del Paggio JC, et al. Br J Surg. 2017 Jul;104(8):1087-1096. doi: 10.1002/bjs.10540. Epub 2017 May 24. Br J Surg. 2017. PMID: 28542954 Free PMC article.

7

Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.

Del Paggio JC, Sullivan R, Schrag D, Hopman WM, Azariah B, Pramesh CS, Tannock IF, Booth CM. Del Paggio JC, et al. Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2. Lancet Oncol. 2017. PMID: 28583794

8

Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies.

Del Paggio JC, Sullivan R, Hopman WM, Booth CM. Del Paggio JC, et al. Ann Oncol. 2018 Mar 1;29(3):773-774. doi: 10.1093/annonc/mdx721. Ann Oncol. 2018. PMID: 29112709 Free article. No abstract available.

9

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.

Tibau A, Molto C, Ocana A, Templeton AJ, Del Carpio LP, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. Among authors: del carpio lp, del paggio jc. J Natl Cancer Inst. 2018 May 1;110(5):486-492. doi: 10.1093/jnci/djx232. J Natl Cancer Inst. 2018. PMID: 29244173

10

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.

Tibau A, Molto C, Borrell M, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. Among authors: del paggio jc. JAMA Oncol. 2018 Nov 1;4(11):1610-1611. doi: 10.1001/jamaoncol.2018.4300. JAMA Oncol. 2018. PMID: 30267037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters